U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H17NO4
Molecular Weight 299.3212
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of N-CAFFEOYLTYRAMINE

SMILES

OC1=CC=C(CCNC(=O)\C=C\C2=CC(O)=C(O)C=C2)C=C1

InChI

InChIKey=VSHUQLRHTJOKTA-XBXARRHUSA-N
InChI=1S/C17H17NO4/c19-14-5-1-12(2-6-14)9-10-18-17(22)8-4-13-3-7-15(20)16(21)11-13/h1-8,11,19-21H,9-10H2,(H,18,22)/b8-4+

HIDE SMILES / InChI

Molecular Formula C17H17NO4
Molecular Weight 299.3212
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 09:04:42 UTC 2023
Edited
by admin
on Sat Dec 16 09:04:42 UTC 2023
Record UNII
3LZ974DQ9J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-CAFFEOYLTYRAMINE
Common Name English
N-TRANS-CAFFEOYLTYRAMINE
Common Name English
TYPHERAMIDE
Common Name English
TRANS-N-CAFFEOYLTYRAMINE
Common Name English
N-(E)-CAFFEOYL-.LAMBDA.-TYRAMINE
Common Name English
(2E)-3-(3,4-DIHYDROXYPHENYL)-N-(2-(4-HYDROXYPHENYL)ETHYL)-2-PROPENAMIDE
Systematic Name English
Code System Code Type Description
CAS
103188-48-3
Created by admin on Sat Dec 16 09:04:42 UTC 2023 , Edited by admin on Sat Dec 16 09:04:42 UTC 2023
PRIMARY
FDA UNII
3LZ974DQ9J
Created by admin on Sat Dec 16 09:04:42 UTC 2023 , Edited by admin on Sat Dec 16 09:04:42 UTC 2023
PRIMARY
PUBCHEM
9994897
Created by admin on Sat Dec 16 09:04:42 UTC 2023 , Edited by admin on Sat Dec 16 09:04:42 UTC 2023
PRIMARY
DRUG BANK
DB08754
Created by admin on Sat Dec 16 09:04:42 UTC 2023 , Edited by admin on Sat Dec 16 09:04:42 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
A 70% aq. acetone extract prepared from the leaves of N. tabacum was partitioned between EtOAc and H2O. TMV infection inhibition activity of compound 15.3 ? 2.0%.
PARENT -> CONSTITUENT ALWAYS PRESENT
210 uM IC50 vs in vitro prostaglandin synthesis
PARENT -> CONSTITUENT ALWAYS PRESENT
119+-21% Mean adhesion, related to the untreated control) of FITC-labeled H. pylori to AGS cells after 2 h pretreatment with different NPAs (2mM)
PARENT -> CONSTITUENT ALWAYS PRESENT
Amide